000 | 01660 a2200505 4500 | ||
---|---|---|---|
005 | 20250513213201.0 | ||
264 | 0 | _c20000719 | |
008 | 200007s 0 0 eng d | ||
022 | _a1524-4539 | ||
024 | 7 |
_a10.1161/01.cir.101.25.2922 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGivertz, M M | |
245 | 0 | 0 |
_aAcute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. _h[electronic resource] |
260 |
_bCirculation _cJun 2000 |
||
300 |
_a2922-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 |
_aCardiac Output, Low _xdrug therapy |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEndothelin Receptor Antagonists |
650 | 0 | 4 |
_aEndothelin-1 _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNorepinephrine _xblood |
650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
650 | 0 | 4 | _aReceptor, Endothelin A |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
650 | 0 | 4 | _aVasodilation |
650 | 0 | 4 |
_aVasodilator Agents _xadverse effects |
700 | 1 | _aColucci, W S | |
700 | 1 | _aLeJemtel, T H | |
700 | 1 | _aGottlieb, S S | |
700 | 1 | _aHare, J M | |
700 | 1 | _aSlawsky, M T | |
700 | 1 | _aLeier, C V | |
700 | 1 | _aLoh, E | |
700 | 1 | _aNicklas, J M | |
700 | 1 | _aLewis, B E | |
773 | 0 |
_tCirculation _gvol. 101 _gno. 25 _gp. 2922-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.101.25.2922 _zAvailable from publisher's website |
999 |
_c10820061 _d10820061 |